HbA1C and Cancer Risk in Patients with Type 2 Diabetes – A Nationwide Population-Based Prospective Cohort Study in Sweden

• Junmei Miao Jonasson ,

  * E-mail: junmei.miao.jonasson@gmail.com

  Affiliations Center of Registers in Region Västra Götaland, Gothenburg, Sweden, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

  ⨯
• Jan Cederholm,

  Affiliation Department of Public Health and Caring Sciences/Family Medicine and Clinical Epidemiology, Uppsala University, Sweden

  ⨯
• Björn Eliasson,

  Affiliation Department of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Göteborg, Sweden

  ⨯
• Björn Zethelius,

  Affiliations Department of Public Health and Caring Sciences/Geriatrics, Uppsala University, Uppsala, Sweden, Medical Products Agency, Uppsala, Sweden

  ⨯
• Katarina Eeg-Olofsson,

  Affiliation Department of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Göteborg, Sweden

  ⨯
• Soffia Gudbjörnsdottir

  Affiliations Center of Registers in Region Västra Götaland, Gothenburg, Sweden, Department of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Göteborg, Sweden

  ⨯